MDT
Medtronic PLC is a medical technology company. It primarily manufacture and sell device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
Medtronic plc (MDT) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Revisions (D+). The rating has held at C+ for 2 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | B- (3.0) | C (2.3) | B+ (3.6) | B+ (3.6) | D+ (1.6) | C+ (2.8) |
| 2026-11-09 | B- (2.9) | C (2.3) | B+ (3.6) | B (3.4) | D+ (1.6) | C+ (2.8) |
| 2026-11-03 | B- (3.0) | C (2.2) | B+ (3.6) | B (3.2) | D+ (1.6) | C+ (2.7) |
| 2026-11-02 | B- (3.0) | C (2.2) | B+ (3.6) | B- (3.1) | D+ (1.7) | C+ (2.7) |
| 2026-10-26 | B- (3.0) | C (2.2) | B+ (3.6) | B- (3.0) | B- (2.9) | B- (3.0) |